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Summary
The lymphocyte differentiation marker CD8 acts as a coreceptor with the T cell receptor (TCR)
during recognition of peptide presented by major histocompatibility complex (MHC) class I
molecules. The functions of CD8 in the TCR complex are thought to be signaling through
the association of CD8 with the protein tyrosine kinase p56kk and adhesion to MHC class I
through the a3 domain . While the ability of the CD8 a/cx homodimer to bind to classical
MHC class I molecules has been shown, it is unclear whether CD8 can also bind nonclassical
molecules. Ofparticular interest is human histocompatibility leukocyte antigen (HLA)-G which
is expressed on placental cytotrophoblast cells. These cells do not express HLA-A, -B and -C
molecules. In this report, we demonstrate thatCD8 can bind to HLA-G . It is possible, therefore,
that a cell bearing CD8 may interact with HLA-G-expressing cells.
I
n humans three nonclassical MHC class I molecules have
been described human histocompatibility leukocyte antigen
(HLA)-E (1, 2), -F (3), and -G (4) which map to theMHC
complex and which encode expressible proteins. While
mRNA for all three genes has been detected in a number
ofcell lines (5), only expression ofHLA-G on the cell surface
was reported (6, 7) . Because there are no specific antibodies
against HLAE, -F, and -G, specific expression ofHLAG can
only be identified by analysis of labeled cell surface proteins
on two-dimensional polyacrylamide gels (6) . By this approach,
HLA-G was the only HLA molecule expressed on fetal cyto-
trophoblast cells (6) . Cytotrophoblasts invade the maternal
decidualized endometrium and are directly exposed to maternal
lymphoid cells yet the placenta is not normally rejected by
the mother as an allograft . Thus, the ability of HLA-G to
be recognized by immune cells is unclear.
BecauseCD8 can bind toMHC class I molecules including
HLAA2, we decided to determine whetherCD8 could recog-
nize and bind to HLA-G as well . Salter et al . (8) recently
identified a conserved negatively charged loop on theMHC
class I a3 domain that is important for binding to CD8. Single
amino acid substitutions at each position in this loop from
residues 223-229 severely reduced binding to CD8 in a cell-
cell adhesion assay. At position 228 within this loopHLAG
has a valine instead of the conserved threonine found inHLA-
A, B, and C . Based on this difference as well as other differ-
ences, itwould not be predicted from sequence comparisons
that CD8 would bind to HLA-G. To determine whether CD8
could bind to HLA-G, we obtained a cell line, LCL 221, that
was null for expression of classical HLA class I molecules
HLA-A, -B, -C and transferents of this cell line that expressed
either HLAG or HLAA2 (6) . Using a cell-cell adhesion assay,
we found that CD8 could bind toHLAG and that the binding
was similar to the binding to HLA-A2 .
Materials and Methods
Cell Lines.
￿
The lymphoblastoid cell lines: theHLA class I null
mutant 221 and HLA-A2 and HLA-G transfectants of 221 were
obtained from Dr. Robert DeMars . TheHLAG andHLA-A2 line
were created by transfecting a genomic gene for HLA-G or HLA-
A2 respectively in a pHeBo vector into the HLA class I null mu-
tant 721.221 (9) . The HLA-G revertants were grown in the ab-
sence of hygromycin B for 3-4 mo .
Cell-cell Adhesion Assay .
￿
The COS7 transient adhesion assay
was performed as described (10) . Briefly, 3 x 105 COS7 cells were
plated in 35 mm dishes and transfected with SRa296 or SRa296
containing thecDNA for CD8 by lipofection . Lipofectin remained
on the COS7 cells for 18 h . Transfected COS7 cells were used48 h
later in the cell-cell adhesion assay. 10 7 35S-cysteine-labeled UC, 221
or transferents were added to each 35 mm dish in 1.0 ml PBS sup-
plemented with 10% heat-inactivated FCS . The cells were incubated
for 1 h at 37°C . The B cells were poured off and the dishes were
washed seven times. Cells were removed from each dish by adding
0.6 ml PBS containing 1% NP-40 . Then 50 F,1 was placedin aqueous
scintillation fluor and counted to determine the number of cells
bound to the transfected COS7 cells.
For each experiment, the level ofexpression ofCD8 on the trans-
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CD8 antibody. Expression levels were consistently high (10) .
'SS-C~steine Labeling ofB Cells.
￿
108 B cells were labeled with
1 mCi 3 S-cysteine (Amersham Corp., Arlington Heights, IL) for
4 h at 37°C in cysteine-free RPMI containing 10% dialyzed FCS,
washed two times and then used for binding as described above.
After 4 h the specific activity ranged from 12 to 18cpm per B cell .
FACS Analysis.
￿
Cells were washed with Ca", Mg" free PBS
and stained wish saturating concentrations ofanti-HLA class 1/lb
mAb W6/32 (11) or an isotype matched antibody, S4B6, against
murine 11,2, followed by staining with either a 1:50 or 1:25 dilu-
tion ofFITC-conjugated goat anti-mouse IgG (Southern Biotech-
nology Associates, Birmingham, AL) . Propidium iodide was in-
cluded to gate out dead cells. Analysis was performed on a FACScan
(Becton-Dickinson and Co., Mountain View, CA) .
Results and Discussion
The ability of CD8 to bind to HLA-G was determined
using a transient cell-cell adhesion assay (14) . Monkey kidney
cells, COS7, expressing high levels ofSV40 T antigen were
transfected with thecDNA for CD8c t in the pCDJrSRot296
expression vector or with vector alone. 70 h post-transfection
the ability of the CD8+ COS7 cells to bind the HLAA,
-B, -C class I-expressing human B lymphoblastoid cell line,
UC, the HLA class I null line 221, or 221 transferents ex-
pressing HLA-G or HLA-A2 was determined . Because high
levels of expression ofHLA are required for sufficient adhe-
sion, we cloned the 1% brightest expressing HLA-G trans-
ferents using aFACS . After sufficient growth the clones were
analyzed and clones withhomogenous staining patterns were
observed (Fig. 1) . An independent transferent ofmutant 221
expressing HLAA2 had high level expression after initial
growth in hygromycin B (9) .
The ratio of cells binding to CD8 transfected COS7 cells
versus binding to vector alone transfected COS7 cells was
determined for each cell line (Table 1, exp. 1 and 2) . In two
separate experiments the ratio of binding for the lympho-
blastoidB cell line, UC was 5.25 and 8.32 whereas the ratio
for 221 cells which do not express the HLAA, -B, and -C
genes was 0.91 and 0.92 . CD8 binding ratios for the HLA-
A2 transferent were 1.74 and 2.57 . Similar transferents were
previously shown to be positive for binding in a cell-cell adhe-
sion assay using stable CD8+ transferents of Chinese ham-
ster ovary (CHO) cells (12) . The HLAG transferent ratios
of 2.33 and 2.12 are well within the range of binding ratios
observed for the HLAA2 transferents . Thus, within an ex-
periment theUC cells had higher binding than the 221 cells
and theHLAA2 and HLA-G transferents were intermediate.
We obtained the same results in two experiments using the
CHO cell-cell adhesion assay (data not shown) .
To further substantiate that the expression ofHLAG was
responsible for the binding, we grew theHLAG transferents
in medium containing no hygromycin B. Because HLAG
is contained in an EBVbased plasmid which autonomously
replicates and lacks a centromere, there is a certain proba-
bility that a daughter cell will not contain the plasmid . By
growing the cells in nonselectable medium, the proportion
of cells that lose the plasmid can accumulate more rapidly
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Figure 1 .
￿
FACS assayed binding ofHLA class I specific mAb W6/32
(11) to lymphoblastoid cell lines. The fluorescence intensity ofthe B lym-
phoblastoid linesUC and 221, HLA-G transferent (TrG), HLAA2 trans-
ferent (TrA2) and HLA-G revertant (TrG(R)) . Cells were stained either
with the mouse MAb W6/32 (solid line or dash/dot for 221) or an irrele-
vant isotypematched antibody (dotted line) followed by second step staining
with FITC-conjugated goat anti-mouse IgG.
resulting in the loss o¬HLAG expression (13) . These cells
should be genetically identical to the parent line except for
the loss of the HLA-G containing plasmid. After 8 wk of
growth expression of HLA-G was greatly reduced (Fig . 1) .
The expression of HLA-DR, and the B cell antigen CD20
were unchanged (data not shown) . These cells were tested
twice in the COS assay. In both experiments the ratio of
binding oftheHLAG revertants was similar to the 221 cells
versus the ratio ofbinding for the parent HLAG transferents
(Table 1) .
To determine if there was a statistically significant differ-
ence between UC and 221 and between HLAG and 221,
we analyzed the data from the four experiments using the
nonparametric Wilcoxon two-sample test . There was a sig-
nificant difference betweenUC and 221 and betweenHLA-G
and 221 at the p = 0.01 level . Therefore, these results, in
conjunction with the results from the HLA-G revertant
Binding of CD8 to Human Histocompatibility Leukocyte Antigen GTable 1 .
￿
Binding of CD8 to MHC Class 1 and Ib
Expressing Cells
' The HLA-G revertant refers to HLA-G transferents grown in the ab-
sence of hygromycin B for 3-4 mo.
binding assays in which the loss of expression ofHLA-G cor-
related with a lack of binding, demonstrate that CD8 does
bind to HLA-G.
Whether the CD8a/a homodimer binds to HLA-G in
a manner similar to HLA class I molecules such as HLAA2
is unclear. If the binding is similar, then the HLA-G substi-
tution at position 228 in the conserved loop on the MHC
class 10 domain that is important for binding to CD8 may
be tolerated whereas the change to alanine which was made
Receivedfor publication 15 April 1991 and in revised form 12 June 1991.
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by Salter et al. (8) that reduced binding may not. Interest-
ingly, a methionine is present at this position in several mouse
MHC class I alleles which are reported to bind to human
CD8 (14). The significance of this change can be tested by
substituting a valine for threonine in the HLAA2 molecule,
transfecting the mutated gene into cells, and determining if
the transferent can bind to CD8. Alternatively, binding of
HLA-G to CD8a/a could be different from the binding of
classical MHC class I to CD8.
The MHC class I molecules of some monkey species are
most homologous to HLAG and -F. In the cotton-top tamarin
the expressed MHC class I genes are more closely related to
HLA-G than to the HLAA, -B, and -C genes (15) . These
animals can mount CD8+ cytotoxic T cell responses (16).
Our work would support the hypothesis that the CD8 mol-
ecule on these cells is likely to bind to the tamarin class I
molecule.
While extensive studies of the function of classical HLA-
A, -B and -C molecules have been performed, much less is
known about the in vivo function of nonclassical MHC mol-
ecules. The expression of HLAG on cytotrophoblasts sug-
gests a potential in vivo role for this molecule. Although
HLAG is nonpolymorphic it may present peptides from pro-
teins that are polymorphic and differ between mother and
fetus. HLAG counl serve as a recognition element by sup-
pressor T cells which are CD8+ and thus prevent "rejection"
of the fetus. Wei and Orr (5) proposed that HLAG may
play a role in immune surveillance to recognize virally in-
fected tissue, a target for CD8+ cytotoxic T cells. Because
a large proportion of the maternal cells in the decidua are
CD2+, CD3 - large granular lymphocytes that express the
CD56 antigen characteristic of NK cells (17), HLA-G may
play a similar role in protecting cells from NK killing. Re-
cent work (Kovats, S., P Fisch, P. M. Sondel, and R. DeMars,
manuscript submitted for publication) indicates that HLAG
expression can reduce lyticactivity by IL -2 activated NK cells
and ,y6T cells. In humans, some NK cells express the CD8a
homodimer. Therefore, CD8 could participate in recogni-
tion of HLAG either by NK cells or by human T cells. Our
finding that CD8 can recognize and bind to HLA-G sup-
ports and strengthens the hypothesis that expression ofHLAG
is likely to be relevant for immune recognition offetaltissue.
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Experiment
no. Cell type
Cells
per
CD8'
bound
well
CD8-
CD8+ /CD8 -
ratio
(x 101)
1 UC 13.0 2.47 5.25
221 4.52 4.94 0.91
HLA-A2 transferent 13.0 7.43 1.74
HLA-G transferent 18.0 7.7 2.33
2 UC 11.9 1.43 8.32
221 8.15 8.85 0.92
HLA-A2 transferent 13.1 5 .1 2.57
HLA-G transferent 26.5 12.5 2.12
3 UC 25.6 1 .9 13.2
221 5.9 5.3 1.1
HLA-G revertant' 9.0 9.7 0.9
HLA-G transferent 17.8 5 .7 3.1
4 UC 123.0 21 .0 5 .9
221 20.0 18 .0 1 .1
HLA-G revertant" 33.6 33.6 1 .0
HLA-G transferent 138.0 26.5 5 .2References
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